Skip to main content
. 2013 Apr 22;7(1):e3. doi: 10.4081/oncol.2013.e3

Figure 7.

Figure 7.

Evolution of dual insulin-like growth factor 1 receptor/insulin receptor inhibitors derived from an imidazo[1,5-a]pyrazine scaffold and structure-based drug design efforts.